Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251697 (US10100018, Example 33 | US9464060, 33) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.300 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ... | US Patent US9464060 (2016) BindingDB Entry DOI: 10.7270/Q23R0RT0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251697 (US10100018, Example 33 | US9464060, 33) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.300 | n/a | n/a | n/a | n/a | n/a | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i... | US Patent US10100018 (2018) BindingDB Entry DOI: 10.7270/Q2PR7Z0N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251681 (US10100018, Example 17 | US9464060, 17) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.400 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ... | US Patent US9464060 (2016) BindingDB Entry DOI: 10.7270/Q23R0RT0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251681 (US10100018, Example 17 | US9464060, 17) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.400 | n/a | n/a | n/a | n/a | n/a | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i... | US Patent US10100018 (2018) BindingDB Entry DOI: 10.7270/Q2PR7Z0N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251696 (US10100018, Example 32 | US9464060, 32) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.400 | n/a | n/a | n/a | n/a | n/a | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i... | US Patent US10100018 (2018) BindingDB Entry DOI: 10.7270/Q2PR7Z0N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251697 (US10100018, Example 33 | US9464060, 33) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.400 | n/a | n/a | n/a | n/a | n/a | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i... | US Patent US10100018 (2018) BindingDB Entry DOI: 10.7270/Q2PR7Z0N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 5 (Homo sapiens (Human)) | BDBM251697 (US10100018, Example 33 | US9464060, 33) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.400 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA5 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ... | US Patent US9464060 (2016) BindingDB Entry DOI: 10.7270/Q23R0RT0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 5 (Homo sapiens (Human)) | BDBM251696 (US10100018, Example 32 | US9464060, 32) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.400 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA5 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ... | US Patent US9464060 (2016) BindingDB Entry DOI: 10.7270/Q23R0RT0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cholesterol 24-hydroxylase (Homo sapiens (Human)) | BDBM50609199 (CHEMBL5279173) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | UniChem | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251680 (US10100018, Example 16 | US9464060, 16) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i... | US Patent US10100018 (2018) BindingDB Entry DOI: 10.7270/Q2PR7Z0N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251681 (US10100018, Example 17 | US9464060, 17) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i... | US Patent US10100018 (2018) BindingDB Entry DOI: 10.7270/Q2PR7Z0N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251682 (US10100018, Example 18 | US9464060, 18) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ... | US Patent US9464060 (2016) BindingDB Entry DOI: 10.7270/Q23R0RT0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 5 (Homo sapiens (Human)) | BDBM251680 (US10100018, Example 16 | US9464060, 16) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA5 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ... | US Patent US9464060 (2016) BindingDB Entry DOI: 10.7270/Q23R0RT0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 5 (Homo sapiens (Human)) | BDBM251681 (US10100018, Example 17 | US9464060, 17) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA5 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ... | US Patent US9464060 (2016) BindingDB Entry DOI: 10.7270/Q23R0RT0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251682 (US10100018, Example 18 | US9464060, 18) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i... | US Patent US10100018 (2018) BindingDB Entry DOI: 10.7270/Q2PR7Z0N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251678 (US10100018, Example 14 | US9464060, 14) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i... | US Patent US10100018 (2018) BindingDB Entry DOI: 10.7270/Q2PR7Z0N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251696 (US10100018, Example 32 | US9464060, 32) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ... | US Patent US9464060 (2016) BindingDB Entry DOI: 10.7270/Q23R0RT0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251678 (US10100018, Example 14 | US9464060, 14) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i... | US Patent US10100018 (2018) BindingDB Entry DOI: 10.7270/Q2PR7Z0N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251682 (US10100018, Example 18 | US9464060, 18) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i... | US Patent US10100018 (2018) BindingDB Entry DOI: 10.7270/Q2PR7Z0N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 5 (Homo sapiens (Human)) | BDBM251678 (US10100018, Example 14 | US9464060, 14) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA5 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ... | US Patent US9464060 (2016) BindingDB Entry DOI: 10.7270/Q23R0RT0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251696 (US10100018, Example 32 | US9464060, 32) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i... | US Patent US10100018 (2018) BindingDB Entry DOI: 10.7270/Q2PR7Z0N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 5 (Homo sapiens (Human)) | BDBM251682 (US10100018, Example 18 | US9464060, 18) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA5 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ... | US Patent US9464060 (2016) BindingDB Entry DOI: 10.7270/Q23R0RT0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251678 (US10100018, Example 14 | US9464060, 14) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ... | US Patent US9464060 (2016) BindingDB Entry DOI: 10.7270/Q23R0RT0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cholesterol 24-hydroxylase (Homo sapiens (Human)) | BDBM50609193 (CHEMBL5288661) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | UniChem | n/a | n/a | 2.40 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cholesterol 24-hydroxylase (Homo sapiens (Human)) | BDBM50609182 (CHEMBL5276973) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PDB UniChem | PDB | n/a | n/a | 2.70 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Citation and Details | ||||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Lysophosphatidic acid receptor 5 (Homo sapiens (Human)) | BDBM251677 (US10100018, Example 13 | US9464060, 13) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA5 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ... | US Patent US9464060 (2016) BindingDB Entry DOI: 10.7270/Q23R0RT0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251677 (US10100018, Example 13 | US9464060, 13) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i... | US Patent US10100018 (2018) BindingDB Entry DOI: 10.7270/Q2PR7Z0N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
D-amino-acid oxidase (Homo sapiens (Human)) | BDBM210775 (US10463663, Example 4 | US11129828, Example 4 | US...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.70 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Human DAAO enzyme was supplied by the Takeda Pharmaceutical Company (Osaka) and each batch was tested and used at concentrations giving comparable le... | US Patent US9290456 (2016) BindingDB Entry DOI: 10.7270/Q2RF5SW0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
D-amino-acid oxidase (Homo sapiens (Human)) | BDBM210775 (US10463663, Example 4 | US11129828, Example 4 | US...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The functional activity of compounds inhibiting the DAAO enzyme was determined by utilizing the co-product of the catalysis of D-Serine, H2O2 which c... | US Patent US10463663 (2019) BindingDB Entry DOI: 10.7270/Q20K2BXG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
D-amino-acid oxidase (Homo sapiens (Human)) | BDBM210775 (US10463663, Example 4 | US11129828, Example 4 | US...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.70 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Human DAAO enzyme was supplied by the Takeda Pharmaceutical Company (Osaka) and each batch was tested and used at concentrations giving comparable le... | Citation and Details BindingDB Entry DOI: 10.7270/Q27W6GCR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
D-amino-acid oxidase (Homo sapiens (Human)) | BDBM210775 (US10463663, Example 4 | US11129828, Example 4 | US...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Universita degli Studi di Firenze | Assay Description Human DAAO enzyme was supplied by the Takeda Pharmaceutical Company (Osaka) and each batch was tested and used at concentrations giving comparable le... | Bioorg Med Chem Lett 18: 4282-6 (2008) BindingDB Entry DOI: 10.7270/Q2F76FWC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251677 (US10100018, Example 13 | US9464060, 13) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i... | US Patent US10100018 (2018) BindingDB Entry DOI: 10.7270/Q2PR7Z0N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251695 (US10100018, Example 31 | US9464060, 31) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ... | US Patent US9464060 (2016) BindingDB Entry DOI: 10.7270/Q23R0RT0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251677 (US10100018, Example 13 | US9464060, 13) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ... | US Patent US9464060 (2016) BindingDB Entry DOI: 10.7270/Q23R0RT0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 5 (Homo sapiens (Human)) | BDBM251729 (US10100018, Example 65 | US9464060, 65) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA5 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ... | US Patent US9464060 (2016) BindingDB Entry DOI: 10.7270/Q23R0RT0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251729 (US10100018, Example 65 | US9464060, 65) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i... | US Patent US10100018 (2018) BindingDB Entry DOI: 10.7270/Q2PR7Z0N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251725 (US10100018, Example 61 | US9464060, 61) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ... | US Patent US9464060 (2016) BindingDB Entry DOI: 10.7270/Q23R0RT0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251695 (US10100018, Example 31 | US9464060, 31) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i... | US Patent US10100018 (2018) BindingDB Entry DOI: 10.7270/Q2PR7Z0N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251725 (US10100018, Example 61 | US9464060, 61) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i... | US Patent US10100018 (2018) BindingDB Entry DOI: 10.7270/Q2PR7Z0N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cholesterol 24-hydroxylase (Homo sapiens (Human)) | BDBM50609197 (CHEMBL5282804) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | UniChem | n/a | n/a | 4.30 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cholesterol 24-hydroxylase (Homo sapiens (Human)) | BDBM50609191 (CHEMBL5271033) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | UniChem | n/a | n/a | 4.40 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cholesterol 24-hydroxylase (Homo sapiens (Human)) | BDBM50609194 (CHEMBL5269674) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | UniChem | n/a | n/a | 4.70 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cholesterol 24-hydroxylase (Homo sapiens (Human)) | BDBM50609189 (CHEMBL5289771) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | UniChem | n/a | n/a | 4.90 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251695 (US10100018, Example 31 | US9464060, 31) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i... | US Patent US10100018 (2018) BindingDB Entry DOI: 10.7270/Q2PR7Z0N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251730 (US10100018, Example 66 | US9464060, 66) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i... | US Patent US10100018 (2018) BindingDB Entry DOI: 10.7270/Q2PR7Z0N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251731 (US10100018, Example 67 | US9464060, 67) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i... | US Patent US10100018 (2018) BindingDB Entry DOI: 10.7270/Q2PR7Z0N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251726 (US10100018, Example 62 | US9464060, 62) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i... | US Patent US10100018 (2018) BindingDB Entry DOI: 10.7270/Q2PR7Z0N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 1 (Homo sapiens (Human)) | BDBM251729 (US10100018, Example 65 | US9464060, 65) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ... | US Patent US9464060 (2016) BindingDB Entry DOI: 10.7270/Q23R0RT0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 5 (Homo sapiens (Human)) | BDBM251695 (US10100018, Example 31 | US9464060, 31) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA5 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ... | US Patent US9464060 (2016) BindingDB Entry DOI: 10.7270/Q23R0RT0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysophosphatidic acid receptor 5 (Homo sapiens (Human)) | BDBM251730 (US10100018, Example 66 | US9464060, 66) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Engagement of the LPA5 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ... | US Patent US9464060 (2016) BindingDB Entry DOI: 10.7270/Q23R0RT0 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 945 total ) | Next | Last >> |